TY - JOUR
AU - Ryden L.
AU - Tardif J.
AU - Nicholls S.
AU - Grobbee D.
AU - Lincoff A.
AU - Malmberg K.
AU - Buse J.
AU - Henry R.
AU - Wedel H.
AU - Weichert A.
AU - Cannata R.
AU - Schwartz G.
AU - Svensson A.
AU - Volz D.
AU - AleCardio Investigators
AU - Neal Bruce
AD - Department of Cardiovascular Medicine, Cleveland Clinic Coordinating Center for Clinical Research, Cleveland, Ohio.<br/>Montreal Heart Institute Coordinating Center, Universite de Montreal, Montreal, Canada.<br/>Veterans Affairs Medical Center and University of Colorado School of Medicine, Denver.<br/>South Australian Health and Medical Research Institute, University of Adelaide, Adelaide.<br/>Department of Medicine, Karolinska Institutet, Stockholm, Sweden.<br/>George Institute for Global Health, University of Sydney, Sydney, Australia.<br/>Department of Medicine, Karolinska Institutet, Stockholm, Sweden7F. Hoffman-La Roche Ltd, Basel, Switzerland.<br/>Nordic School of Public Health, Frolunda, Sweden.<br/>University of North Carolina School of Medicine, Chapel Hill.<br/>University of California San Diego, San Diego.<br/>F. Hoffman-La Roche Ltd, Basel, Switzerland.<br/>Julius Center for Health Sciences and Primary Care and Julius Clinical, University Medical Center Utrecht, Utrecht, the Netherlands.
AN - 24682069
BT - Journal of the American Medical Association (JAMA)
DP - NLM
ET - 30 March 2014
LA - eng
M1 - 15
N1 - Lincoff, A Michael<br/>Tardif, Jean-Claude<br/>Schwartz, Gregory G<br/>Nicholls, Stephen J<br/>Ryden, Lars<br/>Neal, Bruce<br/>Malmberg, Klas<br/>Wedel, Hans<br/>Buse, John B<br/>Henry, Robert R<br/>Weichert, Arlette<br/>Cannata, Ruth<br/>Svensson, Anders<br/>Volz, Dietmar<br/>Grobbee, Diederick E<br/>AleCardio Investigators<br/>Clinical Trial, Phase III<br/>Multicenter Study<br/>Randomized Controlled Trial<br/>Research Support, Non-U.S. Gov't<br/>United States<br/>JAMA. 2014 Apr 16;311(15):1515-25. doi: 10.1001/jama.2014.3321.
PY - 2014
SN - 1538-3598 (Electronic) - 0098-7484 (Linking)
SP - 1515
EP - 25
T2 - Journal of the American Medical Association (JAMA)
TI - Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial
VL - 311
ER -